March 2016

ESR steps up collaboration in medical radiation protection and imaging biobanks.

Wednesday, March 2, 2016 (ECR) – Medical radiation protection, imaging biomarkers, and biobanks, have been the subject of intense focus on the part of the European Society of Radiology and its committees over the past year, said Professor Luis Donoso Bach, ESR President and director of the Diagnostic Imaging Department of the Hospital Clínic of the University of Barcelona, Spain.

The European Society of Radiology (ESR) and other medical associations – the European Federation of Radiographer Societies (EFRS), the European Federation of Organisations in Medical Physics (EFOMP), the European Association of Nuclear Medicine (EANM), and the European Society for Radiotherapy and Oncology (ESTRO) – have been working to develop a strategic research agenda (SRA) for medical radiation protection, as this field has been underrepresented and fragmented to date. In addition to giving greater visibility to medical radiation protection in the research community, the aim is to also to influence the EU research programme Horizon 2020 by proposing research priorities within its area of expertise.

“The first version of the SRA for medical radiation protection has been reviewed and approved by all medical societies involved. The final version, which will be published soon, will be the first time that the medical community has reached a consensus on a joint approach. This unity will help to ensure greater visibility in radiation protection research and opportunities for funding in future research programmes, which represents a major success for the medical community,” said Prof. Donoso.

The ESR has recently also become a member of MELODI, the Multidisciplinary European Low-Dose Initiative, an organisation promoting low-dose radiation protection research. The ESR’s prior cooperation with MELODI had been governed by a memorandum of understanding signed in 2014, but the ESR’s acceptance as a MELODI member by its General Assembly on November 9 allows the ESR to become an integral, long-term partner in shaping the European radiation protection research landscape, which represents a milestone in the society’s long history of promoting radiation protection.

After publishing its white paper on biobanks last August and bringing together all ESR activities concerning imaging biomarkers under the EIBALL umbrella (European Imaging Biomarkers Alliance), the ESR has taken another major step towards establishing a European biobank concept for medical imaging by starting an official collaboration with the Biobanking and Biomolecular Resources Research Infrastructures – European Research Infrastructure Consortium (BBMRI-ERIC).

“The ESR is particularly pleased with this collaboration with BBMRI-ERIC, which will facilitate development in the integration of imaging data with biobank databases. The main goals of this collaboration are to promote the importance and visibility of imaging biobanks, to coordinate efforts to establish a European imaging biobank infrastructure and to ensure its linking to existing biobanks,” Prof. Donoso is looking forward to the collaboration.

Luis Donoso Bach: Director of the Diagnostic Imaging Department of the Hospital Clínic of the University of Barcelona, Spain; Executive Director of the UDIAT Diagnostic Centre, Health Corporation Parc Taulí; ESR President


Wednesday, March 2, 08:30–10:00, Room L8

EuroSafe Imaging Session 1
Moderator: L. Rainford; Dublin/IE

  • Developing a strategic research agenda for medical radiation protection: a chance for advancing research in radiology
    W. Stiller; Heidelberg/DE
  • Do iodinated contrast media enhance DNA damage after exposure to ionising radiation?
    G. Frija; Paris/FR
  • Dose reduction in modern digital plain-radiography on the basis of indication-specific, standardised quality criteria
    D. Spira; Heidelberg/DE
  • Paediatric imaging: are risks of ionising radiation exposure established?
    H. Ducou le Pointe; Paris/FR

    This session is part of the EuroSafe Imaging campaign
Thursday, March 3, 16:00–17:30, Room F1

PC 8b An introduction to European Imaging Biomarkers Alliance (EIBALL)

  • Chairman’s introduction
    P.M. Parizel; Antwerp/BE
  • EIBALL and its mission
    S. Trattnig; Vienna/AT
  • The potential role of EIBALL for EORTC multicentre trials
    Y. Liu; Brussels/BE
  • The organisational role of EIBIR in EIBALL
    V. Vilgrain; Clichy/FR
  • Imaging biomarker development for EIBALL by subspecialty societies
    K. Nikolaou; Tübingen/DE
  • Panel discussion: What is the role of EIBALL now and in the future?
Friday, March 4, 08:30–10:00, Studio 2016

PC 9a Biobanks meet imaging
Moderators: E.Neri (Pisa/IT) and M.Pasterk (Graz/AT)

  • How does Biobanking and BioMolecular resource Research Infrastructur – European Research Infrastructure Consortium (BBMRI-ERIC) work?
    J.-E. Litton; Graz/AT
  • Patient rights: data overprotection?
    M.T. Mayrhofer; Graz/AT
  • What is the difference between a PACS and a clinical bank of radiological images?
    A. van der Lugt; Rotterdam/NL
  • Population-based cohort biobanks: accessing large European prospective cohorts through the biobanking infrastructure BBMRI – large prospective cohorts (LPC)
    O. Törnwall; Graz/AT
  • Population-based cohort: image banks
    F. Bamberg; Tübingen/DE
  • What are ontologies?
    B.Gibaud; Rennes/FR